Consensus Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Real-time Estimate Cboe BZX 12:30:35 2024-03-28 pm EDT 5-day change 1st Jan Change
20.08 USD +2.74% Intraday chart for Privia Health Group, Inc. +0.85% -12.59%

Evolution of the average Target Price on Privia Health Group, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2b19.oz_-DguEfSQGkOhI8uDhiL4G9O1oe2ZsQX1PnIHBFpA.ywuEPVTTDVVRyLkBw6mP4ulKoN8cHBcGCDcH78jwb9iSTZVkSc46UHT4jw~65d90c9eef09bca7f9ce5cf039565a9b
Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating MT
JPMorgan Cuts Price Target on Privia Health to $30 From $38, Maintains Overweight Rating MT
Barclays Starts Coverage on Privia Health With Equalweight Rating, $22 Price Target MT
UBS Adjusts Privia Health Group Price Target to $29 From $31, Maintains Buy Rating MT
TD Cowen Adjusts Price Target on Privia Health to $26 From $30, Maintains Outperform Rating MT
Truist Securities Cuts Price Target on Privia Health Group to $28 From $32, Maintains Buy Rating MT
RBC Trims Price Target on Privia Health Group to $28 From $32, Keeps Outperform Rating MT
JMP Securities Initiates Privia Health Group With Market Outperform Rating, Price Target is $27 MT
JPMorgan Cuts Privia Health Group's Price Target to $38 From $43, Keeps Overweight Rating MT
UBS Trims Privia Health Group Price Target to $31 From $32, Maintains Buy Rating MT
RBC Cuts Price Target on Privia Health Group to $32 From $36, Keeps Outperform Rating MT
UBS Adjusts Privia Health Price Target to $32 From $35, Maintains Buy Rating MT
TD Cowen Adjusts Price Target on Privia Health to $35 From $44, Maintains Outperform Rating MT
Evercore ISI Group Initiates Privia Health Group at Outperform With $34 Price Target MT
UBS Adjusts Privia Health Price Target to $35 From $30, Maintains Buy Rating MT
Stephens Initiates Privia Health Group at Overweight With $33 Price Target MT
Privia Health Group Initiated at Outperform by RBC, Price Target Set at $36; Firm Highlights Differentiation, Market Size MT
Goldman Sachs Initiates Coverage on Privia Health Group With Buy Rating, $32 Price Target MT
Stifel Starts Privia Health Group at Buy With $28 Price Target MT
UBS Initiates Coverage on Privia Health Group With Buy Rating, $30 Price Target MT
Canaccord Genuity Adjusts Price Target on Privia Health Group to $43 From $50, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Privia Health Group to $54 From $48, Keeps Buy Rating MT
Canaccord Genuity Adjusts Privia Health Group's Price Target to $50 from $45, Maintains Buy Rating MT
Guggenheim Adjusts Privia Health Group's Price Target to $51 from $36, Keeps Buy Rating MT
Truist Securities Adjusts Price Target for Privia Health Group to $48 From $40, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
19.55 USD
Average target price
27.41 USD
Spread / Average Target
+40.21%
High Price Target
37 USD
Spread / Highest target
+89.26%
Low Price Target
21 USD
Spread / Lowest Target
+7.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Privia Health Group, Inc.

Canaccord Genuity
JPMorgan Chase
Barclays
UBS
TD Cowen
Truist Securities
RBC Capital Markets
JMP Securities
Evercore ISI
Stephens Inc.
Goldman Sachs
Stifel Nicolaus
Credit Suisse
Guggenheim
Cowen
SVB Securities LLC
BofA Securities
BTIG
Piper Sandler
SVB Leerink
Jefferies & Co.
William Blair & Co.
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings